

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of somitogenesis (GO:0014807) | 7.82579918 |
| 2 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 5.15293568 |
| 3 | negative regulation of catenin import into nucleus (GO:0035414) | 5.07137622 |
| 4 | replicative senescence (GO:0090399) | 4.88041293 |
| 5 | tooth mineralization (GO:0034505) | 4.80761159 |
| 6 | negative regulation of T-helper cell differentiation (GO:0045623) | 4.62481682 |
| 7 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 4.62481682 |
| 8 | positive regulation of prostaglandin secretion (GO:0032308) | 4.55328685 |
| 9 | righting reflex (GO:0060013) | 4.41804650 |
| 10 | regulation of prostaglandin secretion (GO:0032306) | 4.38886970 |
| 11 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 4.37464400 |
| 12 | growth hormone receptor signaling pathway (GO:0060396) | 4.36238099 |
| 13 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.23539330 |
| 14 | protein K11-linked deubiquitination (GO:0035871) | 4.20887301 |
| 15 | positive regulation of RNA splicing (GO:0033120) | 4.06512855 |
| 16 | positive regulation of protein sumoylation (GO:0033235) | 4.03673663 |
| 17 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.99107256 |
| 18 | regulation of activation of Janus kinase activity (GO:0010533) | 3.98024302 |
| 19 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.91422046 |
| 20 | locomotory exploration behavior (GO:0035641) | 3.90835213 |
| 21 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.88881324 |
| 22 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.88076756 |
| 23 | vocalization behavior (GO:0071625) | 3.86434218 |
| 24 | cellular response to growth hormone stimulus (GO:0071378) | 3.86353305 |
| 25 | detection of chemical stimulus involved in sensory perception of smell (GO:0050911) | 3.85543506 |
| 26 | regulation of DNA damage checkpoint (GO:2000001) | 3.80994201 |
| 27 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.73328116 |
| 28 | neuronal action potential propagation (GO:0019227) | 3.71529837 |
| 29 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.66651748 |
| 30 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.64601299 |
| 31 | negative regulation of type 2 immune response (GO:0002829) | 3.64336368 |
| 32 | synaptic vesicle exocytosis (GO:0016079) | 3.62134417 |
| 33 | glutamate receptor signaling pathway (GO:0007215) | 3.60151043 |
| 34 | regulation of endothelial cell differentiation (GO:0045601) | 3.53922455 |
| 35 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.53066776 |
| 36 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.52228049 |
| 37 | protein prenylation (GO:0018342) | 3.46368809 |
| 38 | prenylation (GO:0097354) | 3.46368809 |
| 39 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 3.46289700 |
| 40 | glutamate secretion (GO:0014047) | 3.44523353 |
| 41 | synaptic vesicle maturation (GO:0016188) | 3.40739373 |
| 42 | protein localization to synapse (GO:0035418) | 3.37617487 |
| 43 | detection of molecule of bacterial origin (GO:0032490) | 3.37295761 |
| 44 | DNA integration (GO:0015074) | 3.36130910 |
| 45 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.31488343 |
| 46 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.31306693 |
| 47 | negative regulation of actin filament bundle assembly (GO:0032232) | 3.31121349 |
| 48 | sulfation (GO:0051923) | 3.30964062 |
| 49 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.30371700 |
| 50 | synaptic transmission, glutamatergic (GO:0035249) | 3.29675240 |
| 51 | hematopoietic stem cell proliferation (GO:0071425) | 3.28431878 |
| 52 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.28327496 |
| 53 | regulation of relaxation of muscle (GO:1901077) | 3.24180920 |
| 54 | leukotriene biosynthetic process (GO:0019370) | 3.23975758 |
| 55 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.23890830 |
| 56 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.23074206 |
| 57 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.20652444 |
| 58 | post-anal tail morphogenesis (GO:0036342) | 3.20479076 |
| 59 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.20236585 |
| 60 | negative regulation of microtubule polymerization (GO:0031115) | 3.17744297 |
| 61 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.17569811 |
| 62 | positive regulation of icosanoid secretion (GO:0032305) | 3.17111514 |
| 63 | regulation of synaptic vesicle transport (GO:1902803) | 3.12652036 |
| 64 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.12115082 |
| 65 | regulation of cell communication by electrical coupling (GO:0010649) | 3.10244305 |
| 66 | chemosensory behavior (GO:0007635) | 3.09084447 |
| 67 | negative regulation of alpha-beta T cell differentiation (GO:0046639) | 3.07032230 |
| 68 | neuron-neuron synaptic transmission (GO:0007270) | 3.06712922 |
| 69 | proline transport (GO:0015824) | 3.06309570 |
| 70 | exploration behavior (GO:0035640) | 3.05876734 |
| 71 | negative regulation of vascular permeability (GO:0043116) | 3.04008569 |
| 72 | long-term memory (GO:0007616) | 3.03006458 |
| 73 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.01869931 |
| 74 | detection of calcium ion (GO:0005513) | 2.99268011 |
| 75 | cellular copper ion homeostasis (GO:0006878) | 2.95699360 |
| 76 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.95188270 |
| 77 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.94196620 |
| 78 | cellular potassium ion homeostasis (GO:0030007) | 2.93863883 |
| 79 | regulation of icosanoid secretion (GO:0032303) | 2.92630147 |
| 80 | regulation of skeletal muscle contraction (GO:0014819) | 2.92068308 |
| 81 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.89752370 |
| 82 | neurotransmitter secretion (GO:0007269) | 2.89499851 |
| 83 | * cAMP biosynthetic process (GO:0006171) | 2.89055559 |
| 84 | neuromuscular process controlling posture (GO:0050884) | 2.88753930 |
| 85 | regulation of synapse structural plasticity (GO:0051823) | 2.86713231 |
| 86 | response to inactivity (GO:0014854) | 2.84118771 |
| 87 | positive regulation of synapse maturation (GO:0090129) | 2.83892736 |
| 88 | regulation of postsynaptic membrane potential (GO:0060078) | 2.83782774 |
| 89 | L-phenylalanine catabolic process (GO:0006559) | 2.83074144 |
| 90 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.83074144 |
| 91 | cell communication by electrical coupling (GO:0010644) | 2.82721954 |
| 92 | regulation of synaptic plasticity (GO:0048167) | 2.80535821 |
| 93 | neuron cell-cell adhesion (GO:0007158) | 2.79886116 |
| 94 | regulation of actin filament-based movement (GO:1903115) | 2.79182717 |
| 95 | positive regulation of fatty acid transport (GO:2000193) | 2.78322968 |
| 96 | gamma-aminobutyric acid transport (GO:0015812) | 2.77839229 |
| 97 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.76173262 |
| 98 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.75392871 |
| 99 | * activation of protein kinase A activity (GO:0034199) | 2.74758850 |
| 100 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.73625437 |
| 101 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.72432973 |
| 102 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.71973519 |
| 103 | protein targeting to Golgi (GO:0000042) | 2.70040899 |
| 104 | behavioral fear response (GO:0001662) | 2.69391871 |
| 105 | behavioral defense response (GO:0002209) | 2.69391871 |
| 106 | positive regulation of membrane potential (GO:0045838) | 2.68659371 |
| 107 | membrane depolarization during action potential (GO:0086010) | 2.67709095 |
| 108 | long term synaptic depression (GO:0060292) | 2.66444777 |
| 109 | detection of chemical stimulus involved in sensory perception (GO:0050907) | 2.64307838 |
| 110 | fear response (GO:0042596) | 2.62209439 |
| 111 | neuron recognition (GO:0008038) | 2.61540186 |
| 112 | cellular response to epinephrine stimulus (GO:0071872) | 2.61406375 |
| 113 | innervation (GO:0060384) | 2.60819872 |
| 114 | cGMP-mediated signaling (GO:0019934) | 2.60639044 |
| 115 | dendritic spine morphogenesis (GO:0060997) | 2.60448307 |
| 116 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.59036831 |
| 117 | regulation of ARF protein signal transduction (GO:0032012) | 2.58055269 |
| 118 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.57055494 |
| 119 | L-phenylalanine metabolic process (GO:0006558) | 2.57055494 |
| 120 | synaptic vesicle endocytosis (GO:0048488) | 2.56612031 |
| 121 | long-term synaptic potentiation (GO:0060291) | 2.55489580 |
| 122 | alanine transport (GO:0032328) | 2.55468585 |
| 123 | neuromuscular process controlling balance (GO:0050885) | 2.54862091 |
| 124 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.53608708 |
| 125 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.53489735 |
| 126 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.52902935 |
| 127 | establishment of protein localization to Golgi (GO:0072600) | 2.52831858 |
| 128 | sarcomere organization (GO:0045214) | 2.52230967 |
| 129 | hepatocyte apoptotic process (GO:0097284) | 2.52164529 |
| 130 | endothelial cell differentiation (GO:0045446) | 2.52056056 |
| 131 | cell communication involved in cardiac conduction (GO:0086065) | 2.51221165 |
| 132 | sodium ion export (GO:0071436) | 2.51051279 |
| 133 | detection of chemical stimulus (GO:0009593) | 2.50428980 |
| 134 | response to epinephrine (GO:0071871) | 2.49693192 |
| 135 | adrenergic receptor signaling pathway (GO:0071875) | 2.49658394 |
| 136 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.49648235 |
| 137 | viral mRNA export from host cell nucleus (GO:0046784) | 2.49516425 |
| 138 | behavioral response to cocaine (GO:0048148) | 2.49114894 |
| 139 | membrane protein ectodomain proteolysis (GO:0006509) | 2.48961622 |
| 140 | leukotriene metabolic process (GO:0006691) | 2.48886362 |
| 141 | inner ear receptor cell development (GO:0060119) | 2.48271193 |
| 142 | dendritic spine organization (GO:0097061) | 2.48121009 |
| 143 | membrane depolarization (GO:0051899) | 2.47119568 |
| 144 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.46383794 |
| 145 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.46159867 |
| 146 | regulation of vesicle fusion (GO:0031338) | 2.46150154 |
| 147 | vesicle transport along microtubule (GO:0047496) | 2.46053236 |
| 148 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.45704533 |
| 149 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.45323931 |
| 150 | transmission of nerve impulse (GO:0019226) | 2.43967286 |
| 151 | heterotypic cell-cell adhesion (GO:0034113) | 2.43648035 |
| 152 | regulation of dendritic spine development (GO:0060998) | 2.43333582 |
| 153 | enteric nervous system development (GO:0048484) | 2.42683451 |
| 154 | insulin secretion (GO:0030073) | 2.40639143 |
| 155 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.40108446 |
| 156 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.39957455 |
| 157 | cellular sodium ion homeostasis (GO:0006883) | 2.39802951 |
| 158 | presynaptic membrane assembly (GO:0097105) | 2.38203610 |
| 159 | cellular response to interleukin-1 (GO:0071347) | 2.38090706 |
| 160 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.37459651 |
| 161 | cardiac muscle hypertrophy (GO:0003300) | 2.37120697 |
| 162 | neurotransmitter transport (GO:0006836) | 2.36221546 |
| 163 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.35965010 |
| 164 | layer formation in cerebral cortex (GO:0021819) | 2.35198875 |
| 165 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.34895966 |
| 166 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.34148310 |
| 167 | response to growth hormone (GO:0060416) | 2.33470254 |
| 168 | regulation of female receptivity (GO:0045924) | 2.33154053 |
| 169 | retina layer formation (GO:0010842) | 2.32368282 |
| 170 | axonal fasciculation (GO:0007413) | 2.32339428 |
| 171 | hair cycle (GO:0042633) | 2.31922445 |
| 172 | molting cycle (GO:0042303) | 2.31922445 |
| 173 | positive regulation of heart rate (GO:0010460) | 2.31361183 |
| 174 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.31030062 |
| 175 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.31030062 |
| 176 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.30546786 |
| 177 | positive regulation of dendritic spine development (GO:0060999) | 2.30426900 |
| 178 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.30194089 |
| 179 | dendrite morphogenesis (GO:0048813) | 2.30016070 |
| 180 | synaptic transmission, dopaminergic (GO:0001963) | 2.29945236 |
| 181 | muscle filament sliding (GO:0030049) | 2.29774414 |
| 182 | actin-myosin filament sliding (GO:0033275) | 2.29774414 |
| 183 | * cAMP metabolic process (GO:0046058) | 2.29118537 |
| 184 | regulation of fatty acid transport (GO:2000191) | 2.26740436 |
| 185 | bone remodeling (GO:0046849) | 2.26666839 |
| 186 | striated muscle hypertrophy (GO:0014897) | 2.25892470 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.86736746 |
| 2 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 4.49813880 |
| 3 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 4.48164173 |
| 4 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 4.04667242 |
| 5 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.23792312 |
| 6 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.54626758 |
| 7 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.49094581 |
| 8 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.41074364 |
| 9 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.27458673 |
| 10 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.26496996 |
| 11 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.25619365 |
| 12 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.25390130 |
| 13 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.19885293 |
| 14 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.16284834 |
| 15 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.15869382 |
| 16 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.15093984 |
| 17 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.15093984 |
| 18 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.11459285 |
| 19 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.09761363 |
| 20 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.04080061 |
| 21 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.95448921 |
| 22 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.84069143 |
| 23 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.81610173 |
| 24 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.77756748 |
| 25 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.77158352 |
| 26 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.75873353 |
| 27 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.75433334 |
| 28 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.71316242 |
| 29 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.69312508 |
| 30 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.68693252 |
| 31 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.62596698 |
| 32 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.61474474 |
| 33 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.60356001 |
| 34 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.58144446 |
| 35 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.57995278 |
| 36 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.57567612 |
| 37 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.55347621 |
| 38 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.55091893 |
| 39 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.53614962 |
| 40 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.52202473 |
| 41 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.50455810 |
| 42 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.49861504 |
| 43 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.42935175 |
| 44 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.42805451 |
| 45 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.41674178 |
| 46 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.40907663 |
| 47 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.39120053 |
| 48 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.36999945 |
| 49 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.35550523 |
| 50 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.30314068 |
| 51 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.29692521 |
| 52 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.28592560 |
| 53 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.26767386 |
| 54 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.26590794 |
| 55 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.26489339 |
| 56 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.26321501 |
| 57 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.22351783 |
| 58 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.21788730 |
| 59 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.21085313 |
| 60 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.19485797 |
| 61 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.17696941 |
| 62 | AR_25329375_ChIP-Seq_VCAP_Human | 1.17561176 |
| 63 | AR_19668381_ChIP-Seq_PC3_Human | 1.16791455 |
| 64 | GATA1_19941826_ChIP-Seq_K562_Human | 1.16470096 |
| 65 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.15688245 |
| 66 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.15130329 |
| 67 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.15078919 |
| 68 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.14407172 |
| 69 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.13505296 |
| 70 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.13470861 |
| 71 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.13382623 |
| 72 | P300_19829295_ChIP-Seq_ESCs_Human | 1.12068068 |
| 73 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.11836323 |
| 74 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.11778548 |
| 75 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.11482394 |
| 76 | GATA1_22025678_ChIP-Seq_K562_Human | 1.10411317 |
| 77 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.09128340 |
| 78 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.08717795 |
| 79 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.08312262 |
| 80 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.07584731 |
| 81 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.07558821 |
| 82 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.07532537 |
| 83 | TCF4_23295773_ChIP-Seq_U87_Human | 1.07039618 |
| 84 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.06992335 |
| 85 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.06633186 |
| 86 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.05826071 |
| 87 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.05593229 |
| 88 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.05377097 |
| 89 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.05298368 |
| 90 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.04469886 |
| 91 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.02000187 |
| 92 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.01431454 |
| 93 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.01008025 |
| 94 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.00880295 |
| 95 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.99461651 |
| 96 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.99224148 |
| 97 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.99224148 |
| 98 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.99223633 |
| 99 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.98927456 |
| 100 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.98834652 |
| 101 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.98772683 |
| 102 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.98733319 |
| 103 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.97596471 |
| 104 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.96935648 |
| 105 | RXR_22108803_ChIP-Seq_LS180_Human | 0.96504806 |
| 106 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.96437485 |
| 107 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.95462177 |
| 108 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.95462177 |
| 109 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.95327472 |
| 110 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.94965630 |
| 111 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.94569945 |
| 112 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.93928829 |
| 113 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.92585958 |
| 114 | * TP53_16413492_ChIP-PET_HCT116_Human | 0.92562199 |
| 115 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.92409111 |
| 116 | VDR_22108803_ChIP-Seq_LS180_Human | 0.91242839 |
| 117 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.91235340 |
| 118 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.90955641 |
| 119 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90282164 |
| 120 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.89789991 |
| 121 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.89622230 |
| 122 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.89534244 |
| 123 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.88951805 |
| 124 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.88131865 |
| 125 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.87973963 |
| 126 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.87777815 |
| 127 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.86718135 |
| 128 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.86669710 |
| 129 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.85984214 |
| 130 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.85733124 |
| 131 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.85698229 |
| 132 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.84270316 |
| 133 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83630406 |
| 134 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.83267231 |
| 135 | GATA2_19941826_ChIP-Seq_K562_Human | 0.82769688 |
| 136 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.82686795 |
| 137 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.81425010 |
| 138 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 0.80368294 |
| 139 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.80135282 |
| 140 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.79579805 |
| 141 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.78054780 |
| 142 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.77565501 |
| 143 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.77065424 |
| 144 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.76554456 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.47520125 |
| 2 | MP0003183_abnormal_peptide_metabolism | 4.02974891 |
| 3 | MP0003880_abnormal_central_pattern | 3.66886882 |
| 4 | MP0005084_abnormal_gallbladder_morpholo | 3.53074898 |
| 5 | MP0004270_analgesia | 3.32022941 |
| 6 | MP0005451_abnormal_body_composition | 3.27015420 |
| 7 | MP0003635_abnormal_synaptic_transmissio | 3.26685857 |
| 8 | MP0002837_dystrophic_cardiac_calcinosis | 3.11088056 |
| 9 | MP0009745_abnormal_behavioral_response | 2.74160755 |
| 10 | MP0002139_abnormal_hepatobiliary_system | 2.71254738 |
| 11 | MP0009764_decreased_sensitivity_to | 2.67386407 |
| 12 | MP0002063_abnormal_learning/memory/cond | 2.65612308 |
| 13 | MP0003221_abnormal_cardiomyocyte_apopto | 2.61834011 |
| 14 | MP0009780_abnormal_chondrocyte_physiolo | 2.61159296 |
| 15 | MP0003950_abnormal_plasma_membrane | 2.59651551 |
| 16 | MP0002163_abnormal_gland_morphology | 2.58646269 |
| 17 | MP0002332_abnormal_exercise_endurance | 2.48667447 |
| 18 | MP0002064_seizures | 2.41571871 |
| 19 | MP0005085_abnormal_gallbladder_physiolo | 2.39860930 |
| 20 | MP0005360_urolithiasis | 2.36117760 |
| 21 | MP0004272_abnormal_basement_membrane | 2.32117909 |
| 22 | MP0005365_abnormal_bile_salt | 2.32034477 |
| 23 | MP0000750_abnormal_muscle_regeneration | 2.31618542 |
| 24 | MP0002909_abnormal_adrenal_gland | 2.29622581 |
| 25 | MP0002822_catalepsy | 2.13882425 |
| 26 | MP0002572_abnormal_emotion/affect_behav | 2.13478090 |
| 27 | MP0005275_abnormal_skin_tensile | 2.05326881 |
| 28 | MP0009046_muscle_twitch | 2.05104150 |
| 29 | MP0008438_abnormal_cutaneous_collagen | 2.02272054 |
| 30 | MP0002272_abnormal_nervous_system | 1.98947164 |
| 31 | MP0001501_abnormal_sleep_pattern | 1.98712505 |
| 32 | MP0005379_endocrine/exocrine_gland_phen | 1.98584476 |
| 33 | MP0001968_abnormal_touch/_nociception | 1.95681176 |
| 34 | MP0003329_amyloid_beta_deposits | 1.89608083 |
| 35 | MP0001440_abnormal_grooming_behavior | 1.88242628 |
| 36 | MP0010368_abnormal_lymphatic_system | 1.84825862 |
| 37 | MP0001958_emphysema | 1.83374768 |
| 38 | MP0001486_abnormal_startle_reflex | 1.76125598 |
| 39 | MP0002734_abnormal_mechanical_nocicepti | 1.74439958 |
| 40 | MP0008875_abnormal_xenobiotic_pharmacok | 1.72700608 |
| 41 | MP0003195_calcinosis | 1.72301004 |
| 42 | MP0000371_diluted_coat_color | 1.68999912 |
| 43 | MP0003879_abnormal_hair_cell | 1.64909436 |
| 44 | MP0002735_abnormal_chemical_nociception | 1.63228450 |
| 45 | MP0002736_abnormal_nociception_after | 1.57583439 |
| 46 | MP0004145_abnormal_muscle_electrophysio | 1.57529488 |
| 47 | MP0010329_abnormal_lipoprotein_level | 1.56714379 |
| 48 | MP0003283_abnormal_digestive_organ | 1.56619510 |
| 49 | MP0003705_abnormal_hypodermis_morpholog | 1.54781707 |
| 50 | MP0000013_abnormal_adipose_tissue | 1.53598189 |
| 51 | MP0000751_myopathy | 1.49244795 |
| 52 | MP0003252_abnormal_bile_duct | 1.48136794 |
| 53 | MP0004130_abnormal_muscle_cell | 1.47475417 |
| 54 | MP0005535_abnormal_body_temperature | 1.47369483 |
| 55 | MP0000569_abnormal_digit_pigmentation | 1.46806764 |
| 56 | MP0002733_abnormal_thermal_nociception | 1.43772370 |
| 57 | MP0004087_abnormal_muscle_fiber | 1.43308260 |
| 58 | MP0004264_abnormal_extraembryonic_tissu | 1.40677255 |
| 59 | MP0002067_abnormal_sensory_capabilities | 1.40172714 |
| 60 | MP0000759_abnormal_skeletal_muscle | 1.39798165 |
| 61 | MP0008961_abnormal_basal_metabolism | 1.38999260 |
| 62 | MP0004043_abnormal_pH_regulation | 1.38609994 |
| 63 | MP0004084_abnormal_cardiac_muscle | 1.37458584 |
| 64 | MP0002106_abnormal_muscle_physiology | 1.35556791 |
| 65 | MP0010386_abnormal_urinary_bladder | 1.35180225 |
| 66 | MP0001661_extended_life_span | 1.33784274 |
| 67 | MP0001970_abnormal_pain_threshold | 1.32336123 |
| 68 | MP0004185_abnormal_adipocyte_glucose | 1.31206007 |
| 69 | MP0000733_abnormal_muscle_development | 1.30677173 |
| 70 | MP0002928_abnormal_bile_duct | 1.30487280 |
| 71 | MP0005423_abnormal_somatic_nervous | 1.29456943 |
| 72 | MP0002972_abnormal_cardiac_muscle | 1.27242202 |
| 73 | MP0005171_absent_coat_pigmentation | 1.23658687 |
| 74 | MP0001879_abnormal_lymphatic_vessel | 1.23472522 |
| 75 | MP0003011_delayed_dark_adaptation | 1.22772054 |
| 76 | MP0003633_abnormal_nervous_system | 1.22745653 |
| 77 | MP0002009_preneoplasia | 1.22365966 |
| 78 | MP0003656_abnormal_erythrocyte_physiolo | 1.22193087 |
| 79 | MP0000604_amyloidosis | 1.21141260 |
| 80 | MP0002877_abnormal_melanocyte_morpholog | 1.20745467 |
| 81 | MP0010234_abnormal_vibrissa_follicle | 1.20312779 |
| 82 | MP0004858_abnormal_nervous_system | 1.19193465 |
| 83 | MP0004233_abnormal_muscle_weight | 1.18551691 |
| 84 | MP0006138_congestive_heart_failure | 1.18102934 |
| 85 | MP0005646_abnormal_pituitary_gland | 1.16990919 |
| 86 | MP0002078_abnormal_glucose_homeostasis | 1.16683964 |
| 87 | MP0000003_abnormal_adipose_tissue | 1.15789858 |
| 88 | MP0004924_abnormal_behavior | 1.15708838 |
| 89 | MP0005386_behavior/neurological_phenoty | 1.15708838 |
| 90 | MP0002118_abnormal_lipid_homeostasis | 1.15165571 |
| 91 | MP0008872_abnormal_physiological_respon | 1.13764752 |
| 92 | MP0008569_lethality_at_weaning | 1.13483149 |
| 93 | MP0002557_abnormal_social/conspecific_i | 1.13467975 |
| 94 | MP0004215_abnormal_myocardial_fiber | 1.13247194 |
| 95 | MP0002127_abnormal_cardiovascular_syste | 1.12993483 |
| 96 | MP0003828_pulmonary_edema | 1.11775606 |
| 97 | MP0005369_muscle_phenotype | 1.11762333 |
| 98 | MP0003868_abnormal_feces_composition | 1.10342458 |
| 99 | MP0001502_abnormal_circadian_rhythm | 1.09336297 |
| 100 | MP0002108_abnormal_muscle_morphology | 1.09236815 |
| 101 | MP0004036_abnormal_muscle_relaxation | 1.07753810 |
| 102 | MP0005165_increased_susceptibility_to | 1.06939090 |
| 103 | MP0004811_abnormal_neuron_physiology | 1.06810491 |
| 104 | MP0002693_abnormal_pancreas_physiology | 1.05912719 |
| 105 | MP0000767_abnormal_smooth_muscle | 1.05383484 |
| 106 | MP0005503_abnormal_tendon_morphology | 1.05352002 |
| 107 | MP0008874_decreased_physiological_sensi | 1.04855022 |
| 108 | MP0004085_abnormal_heartbeat | 1.04829335 |
| 109 | MP0002184_abnormal_innervation | 1.04190728 |
| 110 | MP0000955_abnormal_spinal_cord | 1.04100708 |
| 111 | MP0002066_abnormal_motor_capabilities/c | 1.04078793 |
| 112 | MP0005332_abnormal_amino_acid | 1.02466272 |
| 113 | MP0000747_muscle_weakness | 1.02145129 |
| 114 | MP0001915_intracranial_hemorrhage | 1.01457004 |
| 115 | MP0005220_abnormal_exocrine_pancreas | 0.97842369 |
| 116 | MP0001765_abnormal_ion_homeostasis | 0.96959330 |
| 117 | MP0004484_altered_response_of | 0.96771541 |
| 118 | MP0003631_nervous_system_phenotype | 0.95745058 |
| 119 | MP0001666_abnormal_nutrient_absorption | 0.94897163 |
| 120 | MP0002295_abnormal_pulmonary_circulatio | 0.92588788 |
| 121 | MP0001944_abnormal_pancreas_morphology | 0.92396423 |
| 122 | MP0003646_muscle_fatigue | 0.92291138 |
| 123 | MP0009840_abnormal_foam_cell | 0.92290935 |
| 124 | MP0003091_abnormal_cell_migration | 0.92018779 |
| 125 | MP0005409_darkened_coat_color | 0.90769643 |
| 126 | MP0002876_abnormal_thyroid_physiology | 0.89768865 |
| 127 | MP0005166_decreased_susceptibility_to | 0.89567115 |
| 128 | MP0003690_abnormal_glial_cell | 0.88806603 |
| 129 | MP0005083_abnormal_biliary_tract | 0.88578748 |
| 130 | MP0004510_myositis | 0.88392660 |
| 131 | MP0002069_abnormal_eating/drinking_beha | 0.87488748 |
| 132 | MP0006276_abnormal_autonomic_nervous | 0.87232761 |
| 133 | MP0005167_abnormal_blood-brain_barrier | 0.87007235 |
| 134 | MP0003075_altered_response_to | 0.86253386 |
| 135 | MP0000778_abnormal_nervous_system | 0.84329293 |
| 136 | MP0002269_muscular_atrophy | 0.83893161 |
| 137 | MP0003806_abnormal_nucleotide_metabolis | 0.82200357 |
| 138 | MP0002882_abnormal_neuron_morphology | 0.82133422 |
| 139 | MP0005620_abnormal_muscle_contractility | 0.81910696 |
| 140 | MP0000749_muscle_degeneration | 0.81500735 |
| 141 | MP0004134_abnormal_chest_morphology | 0.81260784 |
| 142 | MP0002229_neurodegeneration | 0.80751458 |
| 143 | MP0004885_abnormal_endolymph | 0.79301501 |
| 144 | MP0003953_abnormal_hormone_level | 0.79238083 |
| 145 | MP0003172_abnormal_lysosome_physiology | 0.78508742 |
| 146 | MP0005388_respiratory_system_phenotype | 0.77948848 |
| 147 | MP0002133_abnormal_respiratory_system | 0.77948848 |
| 148 | MP0000163_abnormal_cartilage_morphology | 0.77903307 |
| 149 | MP0000230_abnormal_systemic_arterial | 0.77770573 |
| 150 | MP0005448_abnormal_energy_balance | 0.75092207 |
| 151 | MP0005187_abnormal_penis_morphology | 0.75051225 |
| 152 | MP0002090_abnormal_vision | 0.74960648 |
| 153 | MP0001544_abnormal_cardiovascular_syste | 0.74954221 |
| 154 | MP0005385_cardiovascular_system_phenoty | 0.74954221 |
| 155 | MP0003191_abnormal_cellular_cholesterol | 0.73813508 |
| 156 | MP0003045_fibrosis | 0.73230769 |
| 157 | MP0005645_abnormal_hypothalamus_physiol | 0.72352327 |
| 158 | MP0002060_abnormal_skin_morphology | 0.70420385 |
| 159 | MP0002638_abnormal_pupillary_reflex | 0.68917825 |
| 160 | MP0002998_abnormal_bone_remodeling | 0.68512738 |
| 161 | MP0005375_adipose_tissue_phenotype | 0.68351664 |
| 162 | MP0002971_abnormal_brown_adipose | 0.67323753 |
| 163 | MP0003279_aneurysm | 0.67258371 |
| 164 | MP0003959_abnormal_lean_body | 0.66633277 |
| 165 | MP0005330_cardiomyopathy | 0.64618972 |
| 166 | MP0000613_abnormal_salivary_gland | 0.64493684 |
| 167 | MP0001270_distended_abdomen | 0.64429510 |
| 168 | MP0002160_abnormal_reproductive_system | 0.63278356 |
| 169 | MP0003300_gastrointestinal_ulcer | 0.63161822 |
| 170 | MP0002089_abnormal_postnatal_growth/wei | 0.61145955 |
| 171 | MP0009384_cardiac_valve_regurgitation | 0.60381418 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oral leukoplakia (HP:0002745) | 7.96396465 |
| 2 | Anomalous pulmonary venous return (HP:0010772) | 7.24823039 |
| 3 | Abnormality of the pulmonary veins (HP:0011718) | 6.49931865 |
| 4 | Focal motor seizures (HP:0011153) | 6.05269699 |
| 5 | Myokymia (HP:0002411) | 4.59321995 |
| 6 | Focal seizures (HP:0007359) | 4.34476255 |
| 7 | Deformed sella turcica (HP:0002681) | 4.22756044 |
| 8 | Visual hallucinations (HP:0002367) | 4.13762937 |
| 9 | Vertebral arch anomaly (HP:0008438) | 3.91614476 |
| 10 | Calf muscle hypertrophy (HP:0008981) | 3.90729242 |
| 11 | Pathologic fracture (HP:0002756) | 3.81470235 |
| 12 | Overgrowth (HP:0001548) | 3.77768843 |
| 13 | Abnormality of the odontoid process (HP:0003310) | 3.76850842 |
| 14 | Slow saccadic eye movements (HP:0000514) | 3.64548603 |
| 15 | J-shaped sella turcica (HP:0002680) | 3.58818503 |
| 16 | Muscle fibrillation (HP:0010546) | 3.55085843 |
| 17 | Tongue fasciculations (HP:0001308) | 3.46667795 |
| 18 | Atonic seizures (HP:0010819) | 3.39086077 |
| 19 | Absence seizures (HP:0002121) | 3.36746475 |
| 20 | Generalized tonic-clonic seizures (HP:0002069) | 3.34379282 |
| 21 | Hyperventilation (HP:0002883) | 3.25081102 |
| 22 | Ketoacidosis (HP:0001993) | 3.21311559 |
| 23 | Short femoral neck (HP:0100864) | 3.20788737 |
| 24 | Broad ribs (HP:0000885) | 3.20276263 |
| 25 | Dialeptic seizures (HP:0011146) | 3.16999992 |
| 26 | Amelogenesis imperfecta (HP:0000705) | 3.14345574 |
| 27 | Abnormality of the sella turcica (HP:0002679) | 3.12308982 |
| 28 | Abnormality of the calf musculature (HP:0001430) | 3.10871038 |
| 29 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.09055671 |
| 30 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.05780748 |
| 31 | Epileptic encephalopathy (HP:0200134) | 3.05156921 |
| 32 | Ketosis (HP:0001946) | 3.01910970 |
| 33 | Flat acetabular roof (HP:0003180) | 3.01846832 |
| 34 | Testicular atrophy (HP:0000029) | 2.99598375 |
| 35 | Action tremor (HP:0002345) | 2.97406631 |
| 36 | Rough bone trabeculation (HP:0100670) | 2.96163662 |
| 37 | Diastasis recti (HP:0001540) | 2.95828062 |
| 38 | Vertebral fusion (HP:0002948) | 2.92323377 |
| 39 | Febrile seizures (HP:0002373) | 2.91139966 |
| 40 | Progressive cerebellar ataxia (HP:0002073) | 2.87648191 |
| 41 | Global brain atrophy (HP:0002283) | 2.84806023 |
| 42 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 2.82447012 |
| 43 | Frequent falls (HP:0002359) | 2.80220898 |
| 44 | Neoplasm of the heart (HP:0100544) | 2.78275724 |
| 45 | Myelomeningocele (HP:0002475) | 2.76198403 |
| 46 | Cerebral inclusion bodies (HP:0100314) | 2.75649800 |
| 47 | Mitral stenosis (HP:0001718) | 2.75332538 |
| 48 | Impaired social interactions (HP:0000735) | 2.72833148 |
| 49 | Abnormal social behavior (HP:0012433) | 2.72833148 |
| 50 | Dysdiadochokinesis (HP:0002075) | 2.71476066 |
| 51 | Distal lower limb muscle weakness (HP:0009053) | 2.70587918 |
| 52 | Thoracolumbar scoliosis (HP:0002944) | 2.70356023 |
| 53 | Status epilepticus (HP:0002133) | 2.70046608 |
| 54 | EMG: myopathic abnormalities (HP:0003458) | 2.69310990 |
| 55 | Dysmetria (HP:0001310) | 2.68460899 |
| 56 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.66838655 |
| 57 | Abnormality of glycolipid metabolism (HP:0010969) | 2.66838655 |
| 58 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.66838655 |
| 59 | Deep venous thrombosis (HP:0002625) | 2.64835804 |
| 60 | Poor eye contact (HP:0000817) | 2.64425855 |
| 61 | Aortic regurgitation (HP:0001659) | 2.63659113 |
| 62 | Exercise-induced myalgia (HP:0003738) | 2.63157320 |
| 63 | Increased connective tissue (HP:0009025) | 2.61854759 |
| 64 | Difficulty climbing stairs (HP:0003551) | 2.61534310 |
| 65 | Supranuclear gaze palsy (HP:0000605) | 2.61199285 |
| 66 | Epileptiform EEG discharges (HP:0011182) | 2.60005840 |
| 67 | Anxiety (HP:0000739) | 2.56302627 |
| 68 | Gaze-evoked nystagmus (HP:0000640) | 2.55950484 |
| 69 | Hyperglycinemia (HP:0002154) | 2.53568386 |
| 70 | Xanthomatosis (HP:0000991) | 2.51880246 |
| 71 | Hypoglycemic coma (HP:0001325) | 2.51497807 |
| 72 | Postural instability (HP:0002172) | 2.51451225 |
| 73 | Neurofibrillary tangles (HP:0002185) | 2.51150635 |
| 74 | Difficulty running (HP:0009046) | 2.49890710 |
| 75 | Intrahepatic cholestasis (HP:0001406) | 2.49315869 |
| 76 | Type 1 muscle fiber predominance (HP:0003803) | 2.49107519 |
| 77 | Depression (HP:0000716) | 2.48966828 |
| 78 | Aplasia/hypoplasia of the femur (HP:0005613) | 2.48525102 |
| 79 | Prolonged partial thromboplastin time (HP:0003645) | 2.48329855 |
| 80 | Sudden death (HP:0001699) | 2.47554344 |
| 81 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.45758773 |
| 82 | Abnormality of the lumbar spine (HP:0100712) | 2.45144216 |
| 83 | Dysmetric saccades (HP:0000641) | 2.45107866 |
| 84 | Muscle fiber splitting (HP:0003555) | 2.43212126 |
| 85 | Abnormality of the intervertebral disk (HP:0005108) | 2.42114228 |
| 86 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.41818997 |
| 87 | Short 4th metacarpal (HP:0010044) | 2.41818997 |
| 88 | Abnormality of the lower motor neuron (HP:0002366) | 2.40192000 |
| 89 | EEG with generalized epileptiform discharges (HP:0011198) | 2.37863208 |
| 90 | Decreased circulating renin level (HP:0003351) | 2.36617689 |
| 91 | Broad-based gait (HP:0002136) | 2.36127555 |
| 92 | Truncal ataxia (HP:0002078) | 2.31895102 |
| 93 | Excessive salivation (HP:0003781) | 2.31237607 |
| 94 | Drooling (HP:0002307) | 2.31237607 |
| 95 | Bundle branch block (HP:0011710) | 2.29564634 |
| 96 | Hyperlipoproteinemia (HP:0010980) | 2.29242991 |
| 97 | Hypoglycemic seizures (HP:0002173) | 2.28433904 |
| 98 | Hyperglycemia (HP:0003074) | 2.28270839 |
| 99 | Skin nodule (HP:0200036) | 2.22015306 |
| 100 | Hypsarrhythmia (HP:0002521) | 2.22012492 |
| 101 | Scanning speech (HP:0002168) | 2.21827213 |
| 102 | Syncope (HP:0001279) | 2.21208736 |
| 103 | Gout (HP:0001997) | 2.19719341 |
| 104 | Premature graying of hair (HP:0002216) | 2.19244009 |
| 105 | Amblyopia (HP:0000646) | 2.18773209 |
| 106 | Impaired vibratory sensation (HP:0002495) | 2.17242090 |
| 107 | Complement deficiency (HP:0004431) | 2.17107355 |
| 108 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.16109822 |
| 109 | Impaired smooth pursuit (HP:0007772) | 2.15944567 |
| 110 | Osteomalacia (HP:0002749) | 2.15892636 |
| 111 | Prominent occiput (HP:0000269) | 2.15005939 |
| 112 | Asymmetric septal hypertrophy (HP:0001670) | 2.13183755 |
| 113 | Ventricular fibrillation (HP:0001663) | 2.12649140 |
| 114 | Genetic anticipation (HP:0003743) | 2.10721648 |
| 115 | Carpal bone hypoplasia (HP:0001498) | 2.10663272 |
| 116 | Abnormal trabecular bone morphology (HP:0100671) | 2.10437520 |
| 117 | Flared iliac wings (HP:0002869) | 2.10387224 |
| 118 | Death in childhood (HP:0003819) | 2.09521674 |
| 119 | Conjugated hyperbilirubinemia (HP:0002908) | 2.08999136 |
| 120 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.08553470 |
| 121 | Hyperkalemia (HP:0002153) | 2.06677378 |
| 122 | Intention tremor (HP:0002080) | 2.06652323 |
| 123 | Muscle fiber inclusion bodies (HP:0100299) | 2.06172687 |
| 124 | Bradykinesia (HP:0002067) | 2.05500871 |
| 125 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.03581925 |
| 126 | Round ear (HP:0100830) | 2.03345131 |
| 127 | Ovoid vertebral bodies (HP:0003300) | 2.02176883 |
| 128 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.01332944 |
| 129 | Hyperglycinuria (HP:0003108) | 1.98634659 |
| 130 | Achilles tendon contracture (HP:0001771) | 1.96890516 |
| 131 | Hypoalphalipoproteinemia (HP:0003233) | 1.94407720 |
| 132 | Abnormality of the 4th metacarpal (HP:0010012) | 1.93396291 |
| 133 | Lipoatrophy (HP:0100578) | 1.93352649 |
| 134 | Resting tremor (HP:0002322) | 1.92259130 |
| 135 | Abnormality of the common coagulation pathway (HP:0010990) | 1.92180736 |
| 136 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.91631531 |
| 137 | Torticollis (HP:0000473) | 1.91522213 |
| 138 | Scapular winging (HP:0003691) | 1.90295486 |
| 139 | Epidermoid cyst (HP:0200040) | 1.87897820 |
| 140 | Abnormality of glycine metabolism (HP:0010895) | 1.86938211 |
| 141 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.86938211 |
| 142 | Generalized myoclonic seizures (HP:0002123) | 1.86427377 |
| 143 | Sparse lateral eyebrow (HP:0005338) | 1.86388590 |
| 144 | Skin pits (HP:0100276) | 1.86359252 |
| 145 | Retinal atrophy (HP:0001105) | 1.86259984 |
| 146 | Aplasia/Hypoplasia involving the pelvis (HP:0009103) | 1.85930138 |
| 147 | Abnormality of the Achilles tendon (HP:0005109) | 1.85478032 |
| 148 | Pheochromocytoma (HP:0002666) | 1.85198517 |
| 149 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.84876419 |
| 150 | Mucopolysacchariduria (HP:0008155) | 1.84876419 |
| 151 | Increased circulating renin level (HP:0000848) | 1.84262009 |
| 152 | Abnormality of the intrinsic pathway (HP:0010989) | 1.83164544 |
| 153 | Long toe (HP:0010511) | 1.81370123 |
| 154 | Thin skin (HP:0000963) | 1.81160938 |
| 155 | Nemaline bodies (HP:0003798) | 1.80949994 |
| 156 | Hemiplegia (HP:0002301) | 1.80828566 |
| 157 | Hyporeflexia of lower limbs (HP:0002600) | 1.80629793 |
| 158 | Hyperammonemia (HP:0001987) | 1.80591566 |
| 159 | Areflexia of lower limbs (HP:0002522) | 1.80261158 |
| 160 | Insidious onset (HP:0003587) | 1.80025773 |
| 161 | Termporal pattern (HP:0011008) | 1.80025773 |
| 162 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.79925959 |
| 163 | Symptomatic seizures (HP:0011145) | 1.79237662 |
| 164 | Confusion (HP:0001289) | 1.79226802 |
| 165 | Focal dystonia (HP:0004373) | 1.79162465 |
| 166 | Agitation (HP:0000713) | 1.78665913 |
| 167 | Neuronal loss in central nervous system (HP:0002529) | 1.77979925 |
| 168 | Rapidly progressive (HP:0003678) | 1.77659330 |
| 169 | Atrial fibrillation (HP:0005110) | 1.76745310 |
| 170 | Blue irides (HP:0000635) | 1.76585205 |
| 171 | Increased variability in muscle fiber diameter (HP:0003557) | 1.76317532 |
| 172 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 1.76080112 |
| 173 | Ventricular arrhythmia (HP:0004308) | 1.75253324 |
| 174 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.74222540 |
| 175 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.73581284 |
| 176 | Distal lower limb amyotrophy (HP:0008944) | 1.71591978 |
| 177 | Striae distensae (HP:0001065) | 1.68803257 |
| 178 | Hemivertebrae (HP:0002937) | 1.67659549 |
| 179 | Dysostosis multiplex (HP:0000943) | 1.66833023 |
| 180 | Short nail (HP:0001799) | 1.65239662 |
| 181 | Meningocele (HP:0002435) | 1.65007390 |
| 182 | Limb-girdle muscle atrophy (HP:0003797) | 1.64158861 |
| 183 | Myocardial infarction (HP:0001658) | 1.62624077 |
| 184 | Myoglobinuria (HP:0002913) | 1.61792232 |
| 185 | Muscular dystrophy (HP:0003560) | 1.59386224 |
| 186 | Thoracic kyphosis (HP:0002942) | 1.59247979 |
| 187 | Preauricular pit (HP:0004467) | 1.58839577 |
| 188 | Periauricular skin pits (HP:0100277) | 1.58839577 |
| 189 | Thickened calvaria (HP:0002684) | 1.57905397 |
| 190 | Aortic aneurysm (HP:0004942) | 1.57875052 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BLK | 9.50259895 |
| 2 | EPHA4 | 5.03318646 |
| 3 | NTRK3 | 4.44665640 |
| 4 | MAP3K9 | 3.64138391 |
| 5 | RIPK4 | 3.12802722 |
| 6 | TLK1 | 2.99005510 |
| 7 | INSRR | 2.56334548 |
| 8 | MAP3K4 | 2.42992116 |
| 9 | KSR2 | 2.23065280 |
| 10 | DAPK2 | 2.20732145 |
| 11 | NTRK1 | 2.04996171 |
| 12 | IRAK3 | 2.00445799 |
| 13 | MAP2K4 | 1.99522463 |
| 14 | MAP3K13 | 1.99039933 |
| 15 | ZAK | 1.90717672 |
| 16 | ARAF | 1.85364937 |
| 17 | PRKD3 | 1.81863522 |
| 18 | MINK1 | 1.68741974 |
| 19 | TTN | 1.60094948 |
| 20 | PAK6 | 1.56009128 |
| 21 | MAP2K7 | 1.56002622 |
| 22 | TGFBR2 | 1.55359292 |
| 23 | MAP3K2 | 1.54661719 |
| 24 | CAMKK1 | 1.52291237 |
| 25 | SIK2 | 1.33313331 |
| 26 | KSR1 | 1.29879371 |
| 27 | CDK5 | 1.27365228 |
| 28 | DAPK1 | 1.25172414 |
| 29 | MARK1 | 1.19811465 |
| 30 | PINK1 | 1.19254130 |
| 31 | FRK | 1.19203899 |
| 32 | STK4 | 1.18891346 |
| 33 | CAMKK2 | 1.17877348 |
| 34 | GRK5 | 1.16673596 |
| 35 | STK38 | 1.15410134 |
| 36 | NEK9 | 1.15376432 |
| 37 | BMPR2 | 1.14497157 |
| 38 | GRK7 | 1.11989648 |
| 39 | PRKCG | 1.10959952 |
| 40 | CAMK2B | 1.07383380 |
| 41 | SGK3 | 1.06900253 |
| 42 | EPHA3 | 1.06007670 |
| 43 | TAOK3 | 1.05727247 |
| 44 | CASK | 1.04503344 |
| 45 | CAMK2A | 1.04204068 |
| 46 | NTRK2 | 1.02372801 |
| 47 | FES | 1.02264439 |
| 48 | PHKG2 | 1.02176678 |
| 49 | PHKG1 | 1.02176678 |
| 50 | PTK2B | 1.02057946 |
| 51 | AKT3 | 1.01358192 |
| 52 | PNCK | 0.99790365 |
| 53 | KDR | 0.98815407 |
| 54 | MAP3K1 | 0.98634134 |
| 55 | PLK2 | 0.98102534 |
| 56 | CAMK1 | 0.93860750 |
| 57 | RAF1 | 0.93478826 |
| 58 | PDPK1 | 0.92951002 |
| 59 | MARK2 | 0.92645372 |
| 60 | MAP3K7 | 0.91040789 |
| 61 | CAMK1G | 0.90838345 |
| 62 | RIPK1 | 0.90347515 |
| 63 | PDK1 | 0.88602181 |
| 64 | RET | 0.87616910 |
| 65 | SYK | 0.87256593 |
| 66 | MAP3K12 | 0.84988028 |
| 67 | EPHA2 | 0.84561535 |
| 68 | STK24 | 0.84130523 |
| 69 | SGK2 | 0.83301967 |
| 70 | SGK494 | 0.81482150 |
| 71 | SGK223 | 0.81482150 |
| 72 | NME1 | 0.81325721 |
| 73 | PRKCH | 0.80017046 |
| 74 | DMPK | 0.79359324 |
| 75 | SGK1 | 0.79152297 |
| 76 | CAMK2D | 0.78283099 |
| 77 | PAK3 | 0.75874903 |
| 78 | BCKDK | 0.73533965 |
| 79 | FER | 0.72132791 |
| 80 | CAMK1D | 0.71624435 |
| 81 | STK11 | 0.71347831 |
| 82 | GRK6 | 0.71307378 |
| 83 | TRIB3 | 0.71289077 |
| 84 | CAMK2G | 0.69183475 |
| 85 | TNIK | 0.68723608 |
| 86 | MAP2K3 | 0.66107647 |
| 87 | RPS6KA5 | 0.65194553 |
| 88 | PRPF4B | 0.64480221 |
| 89 | PDGFRB | 0.64072486 |
| 90 | ABL2 | 0.63689314 |
| 91 | PIM1 | 0.63513192 |
| 92 | STK3 | 0.63253656 |
| 93 | BRAF | 0.63137355 |
| 94 | PRKCE | 0.62003644 |
| 95 | TYRO3 | 0.61304902 |
| 96 | LMTK2 | 0.60403524 |
| 97 | MAP2K1 | 0.59453155 |
| 98 | HIPK2 | 0.59433403 |
| 99 | PDK3 | 0.58849903 |
| 100 | PDK4 | 0.58849903 |
| 101 | NEK6 | 0.58181245 |
| 102 | PKN2 | 0.58020335 |
| 103 | PKN1 | 0.56995294 |
| 104 | CDC42BPA | 0.56371329 |
| 105 | FGR | 0.55604504 |
| 106 | CSNK1G2 | 0.54779198 |
| 107 | WNK4 | 0.54300244 |
| 108 | DAPK3 | 0.53974641 |
| 109 | MAP4K1 | 0.52166875 |
| 110 | RPS6KA3 | 0.51764918 |
| 111 | SIK1 | 0.51244167 |
| 112 | MAPK13 | 0.50895057 |
| 113 | TAOK1 | 0.50180696 |
| 114 | JAK2 | 0.49761097 |
| 115 | PIK3CG | 0.49738502 |
| 116 | PRKAA2 | 0.49418533 |
| 117 | CAMK4 | 0.47310216 |
| 118 | STK38L | 0.46026414 |
| 119 | PTK2 | 0.45839571 |
| 120 | PDGFRA | 0.44338585 |
| 121 | PRKD2 | 0.44219092 |
| 122 | EEF2K | 0.44082939 |
| 123 | MAPK10 | 0.43979249 |
| 124 | PRKAA1 | 0.43895931 |
| 125 | MAP3K5 | 0.43564039 |
| 126 | WNK1 | 0.42875529 |
| 127 | PRKCZ | 0.42627070 |
| 128 | MAPK12 | 0.42619149 |
| 129 | SCYL2 | 0.41575011 |
| 130 | STK39 | 0.40691208 |
| 131 | MAP3K6 | 0.39856128 |
| 132 | OBSCN | 0.39592268 |
| 133 | MOS | 0.39496817 |
| 134 | DYRK1A | 0.39344320 |
| 135 | HCK | 0.39014296 |
| 136 | FGFR3 | 0.38840637 |
| 137 | PRKACA | 0.38557118 |
| 138 | PDK2 | 0.36563028 |
| 139 | CSK | 0.35704312 |
| 140 | MAP3K3 | 0.35099063 |
| 141 | IRAK4 | 0.34854547 |
| 142 | VRK1 | 0.34696840 |
| 143 | LYN | 0.34327784 |
| 144 | RPS6KA2 | 0.34242198 |
| 145 | MAPK4 | 0.33818457 |
| 146 | IKBKE | 0.33269647 |
| 147 | TRPM7 | 0.33003922 |
| 148 | RPS6KA6 | 0.32718915 |
| 149 | RPS6KC1 | 0.29057876 |
| 150 | RPS6KL1 | 0.29057876 |
| 151 | MUSK | 0.27875797 |
| 152 | ICK | 0.27657118 |
| 153 | AKT2 | 0.27626317 |
| 154 | FYN | 0.27089659 |
| 155 | ADRBK1 | 0.26873848 |
| 156 | ERBB2 | 0.26251840 |
| 157 | MST1R | 0.24181546 |
| 158 | IRAK1 | 0.23691479 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 4.52566652 |
| 2 | Alcoholism_Homo sapiens_hsa05034 | 3.12638667 |
| 3 | Nicotine addiction_Homo sapiens_hsa05033 | 2.67995669 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.54155765 |
| 5 | Long-term potentiation_Homo sapiens_hsa04720 | 2.34188378 |
| 6 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.21089077 |
| 7 | * Insulin secretion_Homo sapiens_hsa04911 | 2.16168374 |
| 8 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.15427256 |
| 9 | * Circadian entrainment_Homo sapiens_hsa04713 | 2.15005466 |
| 10 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.02429311 |
| 11 | * Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.02411611 |
| 12 | * Glutamatergic synapse_Homo sapiens_hsa04724 | 1.99422024 |
| 13 | * GABAergic synapse_Homo sapiens_hsa04727 | 1.88360484 |
| 14 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.87541442 |
| 15 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.81628404 |
| 16 | * Salivary secretion_Homo sapiens_hsa04970 | 1.76619242 |
| 17 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.71816199 |
| 18 | * Morphine addiction_Homo sapiens_hsa05032 | 1.71724236 |
| 19 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.67453386 |
| 20 | * Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.66649674 |
| 21 | * Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.64879260 |
| 22 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.59221058 |
| 23 | Olfactory transduction_Homo sapiens_hsa04740 | 1.57697964 |
| 24 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.52230045 |
| 25 | Renin secretion_Homo sapiens_hsa04924 | 1.51851068 |
| 26 | Taste transduction_Homo sapiens_hsa04742 | 1.51512938 |
| 27 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.38188734 |
| 28 | * Gastric acid secretion_Homo sapiens_hsa04971 | 1.37104525 |
| 29 | * Calcium signaling pathway_Homo sapiens_hsa04020 | 1.36868785 |
| 30 | * Cholinergic synapse_Homo sapiens_hsa04725 | 1.35658741 |
| 31 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.34705081 |
| 32 | Long-term depression_Homo sapiens_hsa04730 | 1.33964188 |
| 33 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.30699792 |
| 34 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.29696471 |
| 35 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.29181377 |
| 36 | * Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.28887966 |
| 37 | * Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.27731105 |
| 38 | * Platelet activation_Homo sapiens_hsa04611 | 1.26095484 |
| 39 | Cocaine addiction_Homo sapiens_hsa05030 | 1.25195778 |
| 40 | * Bile secretion_Homo sapiens_hsa04976 | 1.20954569 |
| 41 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.20932229 |
| 42 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.20927613 |
| 43 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.19732513 |
| 44 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.17155849 |
| 45 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.16755295 |
| 46 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.13443631 |
| 47 | * Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.12531206 |
| 48 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.09899366 |
| 49 | * cAMP signaling pathway_Homo sapiens_hsa04024 | 1.09671916 |
| 50 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.08465927 |
| 51 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.06325875 |
| 52 | * GnRH signaling pathway_Homo sapiens_hsa04912 | 1.04443462 |
| 53 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.02555401 |
| 54 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.01421641 |
| 55 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.00779328 |
| 56 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.99543909 |
| 57 | Leishmaniasis_Homo sapiens_hsa05140 | 0.99213466 |
| 58 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.99086292 |
| 59 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.98728669 |
| 60 | * cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.98711301 |
| 61 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.96760583 |
| 62 | Focal adhesion_Homo sapiens_hsa04510 | 0.95731492 |
| 63 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.94418577 |
| 64 | * Pancreatic secretion_Homo sapiens_hsa04972 | 0.94399935 |
| 65 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.94392293 |
| 66 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.93597305 |
| 67 | * Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.92458425 |
| 68 | Tuberculosis_Homo sapiens_hsa05152 | 0.91316121 |
| 69 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.90064354 |
| 70 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.90035596 |
| 71 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.88638527 |
| 72 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.87269227 |
| 73 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.86792700 |
| 74 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.86336457 |
| 75 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.85939035 |
| 76 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.84726334 |
| 77 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.84515223 |
| 78 | * Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.84315297 |
| 79 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.83202966 |
| 80 | * Gap junction_Homo sapiens_hsa04540 | 0.78730222 |
| 81 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.78587279 |
| 82 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.78207163 |
| 83 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.77071540 |
| 84 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.75420509 |
| 85 | Bladder cancer_Homo sapiens_hsa05219 | 0.75116132 |
| 86 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.74865705 |
| 87 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.74817072 |
| 88 | Glioma_Homo sapiens_hsa05214 | 0.74057896 |
| 89 | * Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.72980878 |
| 90 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.72894246 |
| 91 | * Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.72495424 |
| 92 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.70517506 |
| 93 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.69908165 |
| 94 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.69765714 |
| 95 | * Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.69148172 |
| 96 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.67892303 |
| 97 | * Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.67175618 |
| 98 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.66556687 |
| 99 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.64154795 |
| 100 | ABC transporters_Homo sapiens_hsa02010 | 0.63985216 |
| 101 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.63955572 |
| 102 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.63452116 |
| 103 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.63100603 |
| 104 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.60843272 |
| 105 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.59367235 |
| 106 | * Melanogenesis_Homo sapiens_hsa04916 | 0.59280316 |
| 107 | Melanoma_Homo sapiens_hsa05218 | 0.59169535 |
| 108 | Prion diseases_Homo sapiens_hsa05020 | 0.59125153 |
| 109 | * Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.58743531 |
| 110 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.58283924 |
| 111 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.57772963 |
| 112 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.57407606 |
| 113 | Insulin resistance_Homo sapiens_hsa04931 | 0.56785474 |
| 114 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.56671253 |
| 115 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.56506372 |
| 116 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.56449370 |
| 117 | * Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.56139887 |
| 118 | Circadian rhythm_Homo sapiens_hsa04710 | 0.55166055 |
| 119 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.52707407 |
| 120 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.52705999 |
| 121 | * Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.51187226 |
| 122 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.51157458 |
| 123 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.50339121 |
| 124 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.50292984 |
| 125 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.50089129 |
| 126 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.49722468 |
| 127 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.49591850 |
| 128 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.47736002 |
| 129 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.47730679 |
| 130 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.46354735 |
| 131 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.46287087 |
| 132 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.46209126 |
| 133 | Hepatitis C_Homo sapiens_hsa05160 | 0.45070009 |
| 134 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.44703871 |
| 135 | Amoebiasis_Homo sapiens_hsa05146 | 0.44060941 |
| 136 | * Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.44057286 |
| 137 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.42500903 |
| 138 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.42363810 |
| 139 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.41613842 |
| 140 | Peroxisome_Homo sapiens_hsa04146 | 0.41306984 |
| 141 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.40819042 |
| 142 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.38213142 |
| 143 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.37977188 |
| 144 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.37679535 |
| 145 | * Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.37423197 |
| 146 | Alzheimers disease_Homo sapiens_hsa05010 | 0.35864544 |
| 147 | * Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.35299421 |
| 148 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.35126510 |

